| Subscribe To Our Free Newsletter |
Emcure Pharma Q2 PAT rises 38.2% YoY
Emcure Pharmaceuticals announces strong Q2FY25 with 20% revenue growth and 38% profit after tax growth.
The Most Valuable Commodity Is Information!
